Related Experiment Videos
[Cancer mortality in Chile: epidemiological considerations]
1Escuela de Salud Pública, Facultad de Medicina, Universidad de Chile. emedina@machi.med.uchile.cl
Revista Medica De Chile
|January 5, 2002
Summary
Cancer mortality is rising in Chile, with stomach, lung, and prostate cancers posing the greatest risks. Delayed diagnosis and treatment contribute to this concerning trend, highlighting the need for improved cancer screening programs.
Area of Science:
- Oncology
- Public Health
- Epidemiology
Context:
- Malignancies represent the second leading cause of mortality in Chile, contributing 21.8% of all deaths.
- Cancer mortality rates exhibit an upward trend, increasing from 99 to 118 per 100,000 population between 1980 and 1998.
- Key cancer sites include stomach, lung, and prostate in men, and gallbladder, stomach, breast, and uterine cervix in women.
Purpose:
- To analyze trends in cancer mortality in Chile.
- To identify specific cancer types with increasing or decreasing mortality rates.
- To discuss the association between diagnostic/therapeutic delays and cancer mortality, and propose screening program actions.
Summary:
- Cancer mortality in Chile shows an overall upward trend, with significant increases observed in prostate, lung, gallbladder, colon, and kidney cancers between 1990-1998.
- Age-adjusted analyses reveal an increased risk for prostate, kidney, colon, skin, and myeloma, independent of population aging.
- Conversely, age-adjusted rates indicate downward trends for uterine cervix, stomach, breast, and esophagus cancers.
Impact:
- The study highlights the growing burden of cancer in Chile, emphasizing the need for targeted interventions.
- Findings underscore the critical role of early detection and timely treatment in mitigating cancer mortality.
- Recommendations for enhancing cancer screening programs are crucial for public health policy and resource allocation.